3-(2,2,2-trimethylhydrazine)propionate has been researched along with natriuretic peptide, brain in 1 studies
| Studies (3-(2,2,2-trimethylhydrazine)propionate) | Trials (3-(2,2,2-trimethylhydrazine)propionate) | Recent Studies (post-2010) (3-(2,2,2-trimethylhydrazine)propionate) | Studies (natriuretic peptide, brain) | Trials (natriuretic peptide, brain) | Recent Studies (post-2010) (natriuretic peptide, brain) |
|---|---|---|---|---|---|
| 251 | 35 | 105 | 16,317 | 1,867 | 8,887 |
| Protein | Taxonomy | 3-(2,2,2-trimethylhydrazine)propionate (IC50) | natriuretic peptide, brain (IC50) |
|---|---|---|---|
| Atrial natriuretic peptide receptor 1 | Homo sapiens (human) | 0.006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cherniatina, MA; Kharchenko, AV; Mikhin, VP; Panchenko, GV; Tsukanova, IuA | 1 |
1 trial(s) available for 3-(2,2,2-trimethylhydrazine)propionate and natriuretic peptide, brain
| Article | Year |
|---|---|
[Efficiency of meldonium in the complex therapy of acute coronary syndrome].
Topics: Acute Coronary Syndrome; Cardiovascular Agents; Coronary Angiography; Diastole; Drug Administration Routes; Drug Monitoring; Electrocardiography; Female; Humans; Male; Methylhydrazines; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Treatment Outcome; Ventricular Function, Left | 2014 |